Medicalsystem Biotechnology (300439.SZ) subsidiary obtains three medical device registration certificates.

Medicalsystem Biotechnology (300439.SZ) announced that its holding subsidiary, Jiangxi Meikangshengde Biotechnology Co., Ltd. (referred to as "Jiangxi Meikang"), has obtained the "Medical Device Registration Certificate (In-Vitro Diagnostic Reagent)" issued by the Jiangxi Provincial Food and Drug Administration. The products include: Trace Element Detection Kit (Inductively Coupled Plasma Mass Spectrometry), Trace Element Quality Control Products, and Uric Acid/Creatinine/Urea Detection Kit (Dry Chemistry Method). The acquisition of the above-mentioned "registration certificate" enriches the variety of the company's product line in the field of in-vitro diagnostic mass spectrometry and POCT, which is beneficial for further enhancing the company's core competitiveness and market expansion capabilities. It will have a positive impact on the company's future operations.